Varaico: Literature-Extracted Genetic Variants

Gene:PMM2
Variant:p.D223N
Back to variants list

PMM2

NM_000303.3:p.D223N

Associated Papers

Targeted metabolomic evaluation of peripheral blood mononucleated cells from patients with PMM2-CDG.

Mangione R et al.

Scientific Reports, 2025

A comprehensive update of genotype-phenotype correlations in PMM2-CDG: insights from molecular and structural analyses.

Oliveira T et al.

Orphanet Journal of Rare Diseases, 2025

Clinical severity and cardiac phenotype in phosphomannomutase 2-congenital disorders of glycosylation : Insights into genetics and management recommendations.

Holubova V et al.

Journal of Inherited Metabolic Disease, 2025

Instrumented assessment of gait disturbance in PMM2-CDG adults: a feasibility analysis.

Cirnigliaro L et al.

Orphanet Journal of Rare Diseases, 2024

Genotype/Phenotype Relationship: Lessons From 137 Patients With PMM2-CDG.

Pajusalu S et al.

Human Mutation, 2024

Catching the Culprit: How Chorea May Signal an Inborn Error of Metabolism.

Ortigoza-Escobar JD

Tremor and Other Hyperkinetic Movements (new York, N.y.), 2023

37810989 (PubMed )
Supplement: tohm-13-1-801-s4.xlsx › Hoja1

Insight on molecular pathogenesis and pharmacochaperoning potential in phosphomannomutase 2 deficiency, provided by novel human phosphomannomutase 2 structures.

Briso-Montiano A et al.

Journal of Inherited Metabolic Disease, 2022

Identification of potential inhibitors against pathogenic missense mutations of PMM2 using a structure-based virtual screening approach.

Thirumal Kumar D et al.

Journal of Biomolecular Structure & Dynamics, 2021

New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach.

Francisco R et al.

Journal of Clinical Medicine, 2020

32635232 (PubMed )
Supplement: jcm-09-02092-s001.pdf

Hyperkinetic movement disorders in congenital disorders of glycosylation.

Mostile G et al.

European Journal of Neurology, 2019

In vitro treatment of congenital disorder of glycosylation type Ia using PLGA nanoparticles loaded with GDP‑Man.

Bortot B et al.

International Journal of Molecular Medicine, 2019

Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides.

Haeuptle MA et al.

Human Mutation, 2009

DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG).

Schollen E et al.

European Journal of Human Genetics : Ejhg, 2002

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."